IRIS
TROVATO, Maria Concetta
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.195
EU - Europa 2.048
AS - Asia 618
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 3
AF - Africa 1
SA - Sud America 1
Totale 4.870
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.190
IE - Irlanda 532
SE - Svezia 521
CN - Cina 354
UA - Ucraina 241
SG - Singapore 235
DE - Germania 201
FR - Francia 181
IT - Italia 161
FI - Finlandia 101
GB - Regno Unito 62
BE - Belgio 18
IN - India 13
RU - Federazione Russa 11
IR - Iran 6
CA - Canada 5
CZ - Repubblica Ceca 5
EU - Europa 4
KR - Corea 3
NL - Olanda 3
NZ - Nuova Zelanda 3
AT - Austria 2
CH - Svizzera 2
AZ - Azerbaigian 1
CL - Cile 1
DK - Danimarca 1
EG - Egitto 1
ES - Italia 1
ID - Indonesia 1
IL - Israele 1
LV - Lettonia 1
MD - Moldavia 1
MM - Myanmar 1
PK - Pakistan 1
PT - Portogallo 1
RO - Romania 1
RS - Serbia 1
SA - Arabia Saudita 1
TR - Turchia 1
Totale 4.870
Salva come PNG Salva come JPEG
Città #
Dublin 531
Jacksonville 495
Chandler 351
Nyköping 243
Singapore 193
Beijing 176
Ashburn 111
Princeton 100
Cambridge 97
Ann Arbor 86
Medford 85
Des Moines 69
Dearborn 60
Messina 47
Boardman 44
Wilmington 34
Woodbridge 31
Bremen 29
Jinan 27
San Mateo 23
Nanjing 22
Mazzarra Sant'andrea 19
Brussels 18
Shenyang 16
Lancaster 15
Munich 15
Falls Church 14
Houston 13
Taizhou 12
Hangzhou 11
Seattle 11
Tianjin 11
Los Angeles 10
Haikou 9
New York 9
Helsinki 8
Zhengzhou 8
Acireale 7
Clearwater 7
Guangzhou 7
Hebei 7
Auburn Hills 6
Fuzhou 6
Ningbo 6
Changsha 5
Hyderabad 5
Leawood 5
Norwalk 5
Pune 5
Ardabil 4
Jiaxing 4
Lanzhou 4
Nanchang 4
Rome 4
Washington 4
Brno 3
Fairfield 3
Giffoni Valle Piana 3
Kemerovo 3
Palermo 3
Parma 3
Redmond 3
Saint Petersburg 3
Toronto 3
Augusta 2
Catania 2
Forlì 2
Giarre 2
Kunming 2
Milan 2
Modica 2
Monmouth Junction 2
Novokuznetsk 2
Paternò 2
Prague 2
Redwood City 2
Sabz 2
Strasbourg 2
Taiyuan 2
Tappahannock 2
Turin 2
Vienna 2
Ancona 1
Atlanta 1
Austin 1
Baku 1
Bangalore 1
Bari 1
Belgrade 1
Birmingham 1
Bologna 1
Boston 1
Brasov 1
Cagliari 1
Cairo 1
Calcinelli 1
Caselette 1
Castelnovo 1
Chicago 1
Chisinau 1
Totale 3.229
Salva come PNG Salva come JPEG
Nome #
Clinico-pathological significance of cell-type-specific loss of heterozygosity on chromosome 7q21: analysis of 318 microdissected thyroid lesions 81
Realtà complesse ed epidemiologia di un fenomeno 81
Expression of P53 and isoforms in bening and malignant lesions of the head and neck 81
Serum hepatocyte growth factor is increased in Hashimoto's thyroiditis whether or not it is associated with nodular goiter as compared with healthy non-goitrous individuals 80
Co-expression of interleukin-6 (IL-6) and interleukin-6 receptor (IL-6R) in thyroid nodules is associated with co-expression of CD30 ligand/CD30 receptor 78
APLOTIPI DEL MICROSATELLITE D7S6440 INTERNO AL GENE HIPK2 COME MARCATORI DELLA TIROIDE AUTOIMMUNITARIA 76
CD30 and CD30 ligand (CD30L) expression in decidual samples of spontaneous abortions. 72
Cell-specific loss of heterozygosity (LOH) on chromosome 7q21 in thyroid tumors: analysis on 267 laser capture microdissected thyroid lesions 70
Cellule giganti tipo corpo estraneo nel carcinoma papillare della tiroide 70
Espressione di CD30 e CD30 ligando nelle decidue di aborti spontanei 69
Expression of NA/1 symporter (NIS) in endometrial mucosa of fertile, sterile and post-menopausal women. 68
Allelic loss at 7q21 is a frequent and early event in thyroid follicular tumors. 68
Immunoreactions for P53 isoforms are associated with ultrastructural proliferative profiles in benign thyroid nodules 68
Deposito presso la GenBank della sequenza genica del microsatellite di 360 bp denominato “D7S6440”, trovato nell’Homo sapiens, localizzato nel cromosoma 7q 32-34, all’interno del gene HIPK2, a livello dell’introne 9; con tandem di ripetizione fra 173..198 bp costituito da sequenze “ca”. 66
Distinctive expression of STAT3 in papillary thyroid carcinomas and a subset of follicular adenomas 65
Expression of CD30 ligand and CD30 receptor in normal thyroid and benign and malignant thyroid nodules 63
The tyrosine kinase receptor c-met, its cognate ligand HGF and the tyrosine kinase receptor trasducers STAT3, PI3K and RHO in thyroid nodules associated with Hashimoto's thyroiditis: an immunohistochemical characterization. 61
Cancer Thyroid Nodule: Knowing is Doing 60
Cell-type specifc loss of heterozygosity (LOH) on chromosome 7q21 in thyroid tumors: analysis on 267 laser capture microdissected thyroid lesions 59
Multidrug resistance protein 2 (MRP2) nei carcinomi midollari della tiroide 59
The new era of vaccines: the “nanovaccinology” 59
STAT3 is selectively expressed in papillary thyroid cancer (PTC) and some follicular adenomas 58
Analisi immunoistochimica dei "pathways" del sistema HGF/c-met in noduli tiroidei benigni e maligni. 58
HGF/C-MET system pathways in benign and malignant histotypes of thyroid nodules: an immunohistochemical characterization 58
Immunoexpression of CD30 and CD30 ligand in deciduas from spontaneous abortions 58
Immunoexpression of the hepatocyte growth factor (HGF), HGF- receptor (c-met) and STAT3 on placental tissues from malformed fetuses 57
Compared with healthy controls, serum hepatocyte growth factor (HGF) is increased in the nodular variant of Hashimoto's thyroiditis (HT) more than in the nonnodular variant, whereas serum interleukin-6 (IL-6) is increased regardless of associated thyroid nodules. 57
Expression of transcription factor STAT3 associated to HGF/c-met system in normal and pathological thyroid tissue. 57
Ultrastructural findings of thyrocytes are signatures for an accurate interpretation of cytological aspirates 57
CD£0 ligand (CD30L)/CD30 receptor (CD30) signaling in benign and malignant thyroid nodules 56
Expression of the hepatocyte growth factor and c-met in normal thyroid, non-neoplastic, and neoplastic nodules 56
TP53 polymorphism may contribute to genetic susceptibility to develop Hashimoto's thyroiditis 56
HGF/c-met system targeting PI3K/AKT and STAT3/phosphorylated-STAT3 pathways in pituitary adenomas: an immunohistochemical characterization in view of targeted therapies. 56
Differential expression of the HGF/c-met ligand/receptor signaling and three downstream molecules (STAT3, PI3K, RHO) in benign and malignant thyroid nodules. 55
METODO PER LA DIAGNOSI IN VITRO DI CARCINOMA TIROIDEO 55
Immunoexpression of multidrug-resistance protein 2 and cyclooxygenase 2 in medullary thyroid carcinomas 54
Infezione occulta da virus dell’epatite B in pazienti con epatite cronica virus con correlata valutazione istologica 54
L'espressione di STAT3 èpiù frequentemente associata al sistema HGF7c-met rispetto ad IL-6/IL6R nei carcinomi papillari e negli adenomi follicolari tiroidei 53
Perdita di eterozigosi su 7q21 nella patologia multinodulare della tiroide 53
Espressione immunoistochimica di HGF, c-met e STAT3 in placente da gravidanze con feti malformati 53
Espressione del CDX2 nelle varie fasi dello sviluppo placentare 53
Comparative analysis of diagnostic performance, feasibility and cost of different test-methods for thyroid nodules with indeterminate cytology 53
Coexistence of diffuse large B-cell lymphoma and papillary thyroid carcinoma in a patient affected by hashimoto's thyroiditis 53
Prognostic and predictive biomarkers in thyroid diseases: “magic bullets” for a personalized therapeutic strategy 52
Multidrug-resistance protein 2 (MRP-2) expression in medullary thyroid carcinoma. 51
New Research Communication on Thyroid Tumor Markers 51
What is New on Thyroid Cancer Biomarkers 50
Expression of transcription factor STAY3 associated to HGF/c-met and IL-6/IL-6r sistems in normal and pathologic thyroid tissue 49
SELECTIVE RADIO-GUIDED NECK DISSECTION FOR CERVICAL LYMPH NODE METASTASIS FROM OCCULT THYROID CANCER: REPORT OF A CASE 49
The loss of the p53 activator HIPK2 is responsible for galectin-3 overexpression in well differentiated thyroid carcinomas 49
Aplotipi del microsatellite D7S6440, localizzato nell'introne 9 del gene HIPK2, come marcatori molecolari della tiroidite di Hashimoto 49
Immunodimostrazione dell'antigene K-1 (CD30) nella patologia autoimmune e neoplastica della tiroide. 48
Differential expression of the HGF/c-met ligand/receptor signaling and three downstream molecules (STAT3, PI3K, RHO) in benign and malignant thyroid nodules: possible implications for pharmachologic treatment of the differentiated thyroid cancer (DTC). 48
Serum interleukin-6 levels are increased in HIV-infected patients that develop autoimmune disease during long-term follow-up 48
EGF, TGFA-apla, EGF receptor (EGFR) and somatostatin receptors (SSR2) in acanthosis nigricans (AN) 47
New Research Communication on Thyroid Tumor Markers 47
LACK OF SOMATOSTATIN ANALOGS (SSAS) EFFECTIVENESS IN GONADOTROPIN-SECRETING PITUITARY ADENOMAS: REPORT OF A CASE AND A REVIEW OF THE LITERATURE 47
Compendio di Anatomia Patologica 47
Combined clinical and ultrasound follow-up assists in malignancy detection in Galectin-3 negative Thy-3 thyroid nodules 47
Loss of heterozygosity of the long arm of chromosome 7 in follicular and anaplastic thyroid cancer, but not in papillary thyroid cancer 46
Espressione genica della via p53/HGF/c-met /STAT3 nei feti con malformazioni del sistema nervoso. 45
Serum Levels And Immohistochemical Expression Of Hepatocyte Growth Factor (Hgf) in Hashimoto Thyroiditis 44
Multidrug resistance protein-2 (MRP-2) nel carcinoma midollare della tiroide. 44
Loss of heterozygosity for 7q21.1 and 31.3 is peculiar of follicular and anaplastic, but not papillary, thyroid cancers 44
Expressions of Δ 133 isoforms of P53 in multinodular thyroids: the immunoreactions in benign lesions are correlating with subcellular phenotypes of electron microscopy 44
Espressione dei fattori della morfogenesi negli organi e nelle placente di feti a varie epoche di gestazione 43
Expression of hepatocyte growth factor in Hashimoto's thyroiditis with nodular lesions 43
The use of Laser Capture Microdissection in the identification of new putative oncosoppressor genes in thyroid cancer. 43
EXPRESSION IN DECIDUAL SAMPLES OF SPONTANEOUS ABORTIONS. 43
Repression of the Antiapoptotic Molecule Galectin-3 by Homeodomain-Interacting Protein Kinase 2-Activated p53 Is Required for p53-Induced Apoptosis. 43
La perdita di eterozigosità (LOH) per markers sul braccio lungo del cromosoma 7 (7q) è peculiare dei carcinomi tiroidei follicolari (FTC) e anaplastici (ATC), non dei papillari (PTC). 42
Serum amyloid A (SAA) expression in medullary thyroid cancer (MTC). 42
Distinctive expression of STAT3 in papillary thyroid carcinoma and a subset of follicular adenomas. 42
THE LOSS OF THE P53 ACTIVATOR HIPK2 IS RESPONSIBLE FOR GALECTIN-3 OVEREXPRESSIONIN WELL DIFFERENTIATED THYROID CARCINOMAS 42
EGF, TGF-alpha, EGF receptor (EGFR) and somatostatin receptors 2 (SSR2) in acanthosis nigricans (AN) 42
Thyroid hemiagenesis, Graves' disease and differentiated thyroid cancer: a very rare association: case report and review of literature 42
Hepatocyte growth factor/C-met axis in thyroid cancer: From diagnostic biomarker to therapeutic target 41
Serum levels and immunohistochemical expression of Hepatocyte Growth Factor (HGF) in Hashimoto thyroiditis. 40
Frizzled-1 is down-regulated in follicular thyroid tumours and modulates growth and invasiveness. 39
Immunoexpression of the CD30 ligand/CD30 and IL-6/IL-6R signals in thyroid autoimmune diseases 38
MULTIDRUG-RESISTANCE PROTEIN 2 (MRP2) E CICLO-OSSIGENASI 2 (COX2) NEL CARCINOMA MIDOLLARE DELLA TIROIDE. 38
LOH sul braccio lungo del cromosoma 7 è una frequente alterazione genetica nel carcinoma follicolare ed anaplastico della tiroide. 37
Espressione dlel'hepatocyte growth factor (HGF) e del suo recettore (HGF-R o c-met) nei carcinomi papillari tiroidei. 37
Hepatocyte growth factor (HGF) expression in nodular Hashimoto thyroditis. 37
Hepatocyte growth factor (HGF) expression and circulating levels in nodular Hashimoto's thyroiditis. 35
Nanostructures: between natural environment and medical practice. 35
Immunohistochemical expression of HGF, c-met and transcription-factor STAT3 in colorectal tumors. 33
Polimorfismo dle gene TP53 nrlla tiroidite di Hashimoto (TH). 33
Serum levels and immunochemical expression of hepatocyte growth factor (HGF) in Hashimoto's thyroiditis. 32
Papillary and follicular thyroid carcinomas show LOH in two distinct regions of the long arm of chromosome 7 32
Expression of HGF and HGF-receptor (c-met) in the papillary thyroid cancer (PTC). 32
Loss of heterozygosity of 7q21.1 and 7q31.3 is peculiar of follicular and anaplastic, but not papillary, thyroid cancer. 30
Expression of IL6/IL6R and CD30L/C30 in normal thyroid and thyroid nodules. 30
Dimostrazione immunocitochimica dell'Hepatocyte Growth Factor (HGF) e del suo recettore c-met nel tessuto tiroideo normale e patologico. 29
Serum Amyloid A (SAA) expression by medullary thyroid cancer (MTC). 29
Expression of p53/ HGF/c-met/ STAT3 signal in fetus with malformation of nervous system. 28
Specific haplotypes of a microsatellite markers internal to the HIPK2 gene in Hashimoto thyroditis 28
Single Nucleotide Polymorphisms (SNPs) in exon 4 of p53 as genetic markers of susceptibility for Hashimoto’s thyroiditis (HT) 27
Expression of p53/hgf/c-met/STAT3 signal in fetuses with neural tube defects 26
Interleukin‑6 signalling as a valuable cornerstone for molecular medicine 17
Totale 4.970
Salva come PNG Salva come JPEG
Categoria #
all - tutte 20.453
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.453
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020647 0 0 0 0 18 63 105 139 33 128 159 2
2020/2021647 86 4 177 35 26 88 8 64 7 65 59 28
2021/2022683 6 86 20 34 31 7 44 32 14 110 103 196
2022/20231.524 123 107 64 102 123 171 16 94 653 3 55 13
2023/2024332 31 60 31 46 39 48 4 34 0 7 2 30
2024/2025263 15 32 35 115 66 0 0 0 0 0 0 0
Totale 4.976